Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 20135198)

1.

DNA methylation markers in colorectal cancer.

Kim MS, Lee J, Sidransky D.

Cancer Metastasis Rev. 2010 Mar;29(1):181-206. doi: 10.1007/s10555-010-9207-6. Review.

PMID:
20135198
2.

Epigenetic changes in colorectal cancer.

Kondo Y, Issa JP.

Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):29-39. Review.

PMID:
15000147
3.

Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.

Kuhmann C, Li C, Kloor M, Salou M, Weigel C, Schmidt CR, Ng LW, Tsui WW, Leung SY, Yuen ST, Becker N, Weichenhan D, Plass C, Schmezer P, Chan TL, Popanda O.

Hum Mol Genet. 2014 Apr 15;23(8):2043-54. doi: 10.1093/hmg/ddt599. Epub 2013 Nov 26.

4.

Accumulation of aberrant DNA methylation during colorectal cancer development.

Sakai E, Nakajima A, Kaneda A.

World J Gastroenterol. 2014 Jan 28;20(4):978-87. doi: 10.3748/wjg.v20.i4.978. Review.

5.

NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.

Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G.

BMC Cancer. 2010 Apr 27;10:160. doi: 10.1186/1471-2407-10-160.

6.
7.

[Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].

Matsubara N.

Gan To Kagaku Ryoho. 2010 Sep;37(9):1659-64. Japanese.

PMID:
20841928
8.

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR.

Gastroenterology. 2007 Jan;132(1):127-38. Epub 2006 Sep 20.

PMID:
17087942
9.

Genome-scale analysis of aberrant DNA methylation in colorectal cancer.

Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW.

Genome Res. 2012 Feb;22(2):271-82. doi: 10.1101/gr.117523.110. Epub 2011 Jun 9.

10.

Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.

Lee S, Oh T, Chung H, Rha S, Kim C, Moon Y, Hoehn BD, Jeong D, Lee S, Kim N, Park C, Yoo M, An S.

Int J Oncol. 2012 Mar;40(3):889-98. doi: 10.3892/ijo.2011.1245. Epub 2011 Oct 25.

PMID:
22038115
11.

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.

Mod Pathol. 2006 Aug;19(8):1083-90. Epub 2006 May 12.

12.

Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.

de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, de Bruïne AP, Goldbohm RA, van den Brandt PA, Weijenberg MP, van Engeland M.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3086-96. doi: 10.1158/1055-9965.EPI-09-0289. Epub 2009 Oct 20.

13.

Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.

Greco SA, Chia J, Inglis KJ, Cozzi SJ, Ramsnes I, Buttenshaw RL, Spring KJ, Boyle GM, Worthley DL, Leggett BA, Whitehall VL.

BMC Cancer. 2010 Sep 16;10:494. doi: 10.1186/1471-2407-10-494.

14.

Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.

Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim HC, Chun HK, Grady WM, Kim YS.

Ann Surg Oncol. 2011 Aug;18(8):2338-47. doi: 10.1245/s10434-011-1573-y. Epub 2011 Feb 5.

15.

DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.

Ashktorab H, Daremipouran M, Goel A, Varma S, Leavitt R, Sun X, Brim H.

Epigenetics. 2014 Apr;9(4):503-12. doi: 10.4161/epi.27644. Epub 2014 Jan 17.

16.

DNA methylation biomarker candidates for early detection of colon cancer.

Yi JM, Dhir M, Guzzetta AA, Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM, Ahuja N.

Tumour Biol. 2012 Apr;33(2):363-72. doi: 10.1007/s13277-011-0302-2. Epub 2012 Jan 12.

17.

A panel of genes methylated with high frequency in colorectal cancer.

Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, Rand KN, McEvoy A, Thomas ML, Baker RT, Wattchow DA, Young GP, Lockett TJ, Pedersen SK, Lapointe LC, Molloy PL.

BMC Cancer. 2014 Jan 31;14:54. doi: 10.1186/1471-2407-14-54.

18.

Promoter CpG island methylation markers in colorectal cancer: the road ahead.

Draht MX, Riedl RR, Niessen H, Carvalho B, Meijer GA, Herman JG, van Engeland M, Melotte V, Smits KM.

Epigenomics. 2012 Apr;4(2):179-94. doi: 10.2217/epi.12.9. Review.

PMID:
22449189
19.

The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.

Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N.

Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158.

20.

Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G, Tomao S.

Tumour Biol. 2014 Jul;35(7):6195-206. doi: 10.1007/s13277-014-1845-9. Epub 2014 Mar 28. Review.

PMID:
25051912
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk